Skip to main content
SpringerLink
Log in

IGF-I Treatment of Adult Patients with Laron Syndrome

  • Chapter
  • First Online:
Laron Syndrome - From Man to Mouse

  • 591 Accesses

Core Message

IGF-I treatment of adult Laron syndrome patients for a period of 9 months had beneficial metabolic effects on protein and fat metabolism. An improvement in kidney function was also registered.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  • Abs R, Mattsson AF, Bengtsson BA, Feldt-Rasmussen U, Góth MI, Koltowska-Häggström M, Monson JP, Verhelst J, Wilton P; KIMS Study Group (2005) Isolated growth hormone (GH) deficiency in adult patients: baseline clinical characteristics and responses to GH replacement in comparison with hypopituitary patients. A sub-analysis of the KIMS database. Growth Horm IGF Res 15:349–359

    Google Scholar 

  • Assmann G, Schulte H, von Eckardstein A (1996) Hyper triglyceridemia and elevated lipoprotein(a) are risk factors for major coronary events in middle-aged men. Am J Cardiol 77:1179–1184

    Article  PubMed  CAS  Google Scholar 

  • Bianda T, Schmid C (1998) Effects of short-term treatment with insulin-like growth factor-I and growth hormone on serum lipoprotein (a) in growth hormone-deficient adults. Eur J Endocrinol 138:189–190

    Article  PubMed  CAS  Google Scholar 

  • Jorgensen JOL, Christiansen JS (eds) (2005) Growth hormone deficiency in adults. S. Karger AG, Basel

    Google Scholar 

  • Juul A, Jorgensen JOL (eds) (2000) Growth hormone in adults. Physiological and clinical aspects, 2nd edn. Cambridge, Cambridge University Press

    Google Scholar 

  • Kanety H, Hemi R, Ginsberg S, Pariente C, Yissachar E, Barchoder E, Funahashi T, Laron Z (2009) Total and high molecular weight adiponectin are elevated in patients with Laron syndrome despite marked obesity. Eur J Endocrinol 161(6):837–844

    Google Scholar 

  • Klinger B, Anin S, Flexer Z, Laron Z (1993) IGF-1 treatment of adult patients with Laron syndrome. In: Laron Z, Parks JS (eds) Lessons from Laron syndrome (LS) 1966–1992. Pediatric and adolescent endocrinology, vol. 24. Karger, Basel, pp 27–33

    Google Scholar 

  • Klinger B, Jensen LT, Silbergeld A, Laron Z (1996) Insulin-like growth factor-I raises serum procollagen levels in children and adults with Laron syndrome. Clin Endocrinol 46:423–429

    Article  Google Scholar 

  • Koltowska-Häggström M, Mattsson AF, Monson JP, Kind P, Badia X, Casanueva FF, Busschbach J, Koppeschaar HP, Johannsson G (2006) Does long-term GH replacement ­therapy in hypopituitary adults with GH deficiency normalise quality of life? Eur J Endocrinol 155:109–119

    Article  PubMed  Google Scholar 

  • Laron Z (1996) Metabolic consequences of early growth hormone and insulin-like growth factor-I deficiency. In: Boulton J, Laron Z, Rey J (eds) Long term consequences of early feeding. Nestle Nuitrition Workshop Series, vol 36. Lippincott-Raven, Philadelphia, pp 225–236

    Google Scholar 

  • Laron Z (2001) Consequences of not treating children with Laron syndrome (primary growth hormone insensitivity). J Pediatr Endocrinol Metab 14(suppl 5):1243–1248

    PubMed  Google Scholar 

  • Laron Z (2004) Laron syndrome (primary growth hormone resistance or insensitivity). The personal experience 1958-2003. J Clin Endocrinol Metab 89:1031–1044

    Article  PubMed  CAS  Google Scholar 

  • Laron Z, Butenandt O (eds) (1993) Growth hormone replacement therapy in adults -pros and cons. Freund, Tel Aviv, p 188

    Google Scholar 

  • Laron Z, Ginsberg S, Lilos P, Arbiv M, Vaissman N (2006) Body composition in untreated adult patients with Laron syndrome (primary GH insensitivity). Clin Endocrinol 65:114–117

    Article  CAS  Google Scholar 

  • Laron Z, Ginsberg S, Pariente C, Kanety H (2007) Serum adiponectin levels in patients with Laron syndrome are unexpectedly high (Abstract #P2–67), In: 89th Annual Meeting of The Endocrine Society, Toronto, Canada, Program & Abstracts Book, p 343

    Google Scholar 

  • Laron Z, Klinger B (1994) IGF-I treatment of adult patients with Laron syndrome: preliminary results. Clin Endocrinol 41: 631–638

    Article  CAS  Google Scholar 

  • Laron Z, Klinger B, Erster B, Anin S (1988) Effects of acute administration of insulin like growth factor I in patients with Laron-type dwarfism. Lancet ii:1170–1172

    Google Scholar 

  • Laron Z, Klinger B, Silbergeld A, Wang XL (1997a) Opposing effects of growth hormone and insulin-like growth factor -I on serum lipoprotein (a). ISPAD Workshop on Role of GH and IGF-I in Carbohydrate and Lipid Metabolism. J Pediatr Endocrinol Metab 10(suppl 1):143–149

    Google Scholar 

  • Laron Z, Pertzelan A, Karp M (1968) Pituitary dwarfism with high serum levels of growth hormone. Isr J Med Sci 4:883–894

    PubMed  CAS  Google Scholar 

  • Laron Z, Klinger B, Silbergeld A (1999) Serum insulin-like growth factor-I (IGF-I) levels during long-term IGF-I treatment of children and adults with primary GH resistance (Laron syndrome). J Pediatr Endocrinol Metab 12:145–152

    PubMed  CAS  Google Scholar 

  • Laron Z, Wang XL, Klinger B, Silbergeld A, Wilcken DEL (1996) Insulin-like growth factor-I decreases serum lipoprotein(a) during long-term treatment of patients with Laron syndrome. Metabolism 45:1263–1266

    Article  PubMed  CAS  Google Scholar 

  • Laron Z, Wang XL, Klinger B, Silbergeld A, Wilcken DEL (1997b) Growth hormone increases and insulin-like growth factor-I decreases circulating lipoprotein(a). Eur J Endocrinol 136:377–381

    Article  PubMed  CAS  Google Scholar 

  • Mauras N, Martinez V, Rini A, Guevara-Aguirre J (2000) Recombinant human insulin-like growth factor I has significant anabolic effects in adults with growth hormone receptor deficiency: studies on protein, glucose, and lipid metabolism. J Clin Endocrinol Metab 85:3036–3042

    Article  PubMed  CAS  Google Scholar 

  • Olivecrona H, Johansson AG, Lindh E, Ljunghall S, Berglund L, Angelin B (1995) Hormonal regulation of serum lipoprotein(a) levels. Contrasting effects of growth hormone and insulin-like growth factor-I. Arterioscler Thromb Vasc Biol 15: 847–849

    Article  PubMed  CAS  Google Scholar 

  • Oscarsson J, Ottosson M, Wiklund O, Mårin P, ­Vikman-Adolfsson K, Björntorp P, Edén S (1994) Low dose continuously infused growth hormone results in increased lipoprotein(a) and decreased low density lipoprotein cholesterol ­concentrations in middle-aged men. Clin Endocrinol (Oxf) 41:109–116

    Article  CAS  Google Scholar 

  • Vaccarello MA, Diamond FB Jr, Guevara-Aguirre J, Rosenbloom AL, Fielder PJ, Gargosky S, Cohen P, Wilson K, Rosenfeld RG (1993) Hormonal and metabolic effects and pharmacokinetics of recombinant insulin-like growth factor-I in growth hormone receptor deficiency/Laron syndrome. J Clin Endocrinol Metab 77:273–280

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Research Unit, Schneider Children’s Medical Center of Israel, Kaplan Street 14, 49202, Petah Tikva, Israel

    Zvi Laron

Authors
  1. Zvi Laron
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Zvi Laron .

Editor information

Editors and Affiliations

  1. Endocrinology & Diabetes Research Unit, Schneider Children's Hospital, Kaplan Street 14, Petah Tikva, 49 202, Israel

    Zvi Laron

  2. Edison Biotechnology Institute, Ohio University, Athens, 45701, Ohio, USA

    J. Kopchick

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Berlin Heidelberg

About this chapter

Cite this chapter

Laron, Z. (2011). IGF-I Treatment of Adult Patients with Laron Syndrome. In: Laron, Z., Kopchick, J. (eds) Laron Syndrome - From Man to Mouse. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-11183-9_46

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-11183-9_46

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-11182-2

  • Online ISBN: 978-3-642-11183-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation